Walleye Capital’s Prelude Therapeutics PRLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-83,175
Closed -$172K 2535
2024
Q3
$172K Buy
83,175
+67,946
+446% +$141K ﹤0.01% 1745
2024
Q2
$58K Sell
15,229
-1,151
-7% -$4.39K ﹤0.01% 2138
2024
Q1
$77.6K Buy
+16,380
New +$77.6K ﹤0.01% 2062
2022
Q1
Sell
-41,954
Closed -$522K 2461
2021
Q4
$522K Buy
+41,954
New +$522K 0.02% 938